These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38734215)

  • 1. Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers.
    Williams P; Cotta MO; Tabah A; Sandaradura I; Kanji S; Scheetz MH; Imani S; Elhadi M; Pardos SL; Schellack N; Sanches C; Timsit JF; Xie J; Farkas A; Wilks K; Roberts JA; ;
    Int J Antimicrob Agents; 2024 Aug; 64(2):107192. PubMed ID: 38734215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
    Liebchen U; Paal M; Scharf C; Schroeder I; Grabein B; Zander J; Siebers C; Zoller M
    J Crit Care; 2020 Dec; 60():260-266. PubMed ID: 32932111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International survey of antibiotic dosing and monitoring in adult intensive care units.
    Williams PG; Tabah A; Cotta MO; Sandaradura I; Kanji S; Scheetz MH; Imani S; Elhadi M; Luque-Pardos S; Schellack N; Sanches C; Timsit JF; Xie J; Farkas A; Wilks K; Roberts JA;
    Crit Care; 2023 Jun; 27(1):241. PubMed ID: 37331935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.
    Imani S; Alffenaar JW; Cotta MO; Daveson K; van Hal S; Lau C; Marriott D; Penm J; Roberts JA; Tabah A; Trethewy N; Williams P; Sandaradura I
    Int J Antimicrob Agents; 2020 Dec; 56(6):106180. PubMed ID: 32987102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Children: An Observational Study in a Pediatric Intensive Care Unit.
    de Cacqueray N; Boujaafar S; Bille E; Moulin F; Gana I; Benaboud S; Hirt D; Béranger A; Toubiana J; Renolleau S; Tréluyer JM; Oualha M
    Ther Drug Monit; 2022 Apr; 44(2):319-327. PubMed ID: 35292609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.
    Koch BCP; Muller AE; Hunfeld NGM; de Winter BCM; Ewoldt TMJ; Abdulla A; Endeman H
    Ther Drug Monit; 2022 Feb; 44(1):11-18. PubMed ID: 34772892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
    Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
    Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.
    Ewoldt TMJ; Abdulla A; van den Broek P; Hunfeld N; Bahmany S; Muller AE; Gommers D; Polinder S; Endeman H; Spronk I; Koch BCP
    BMC Infect Dis; 2022 Jul; 22(1):611. PubMed ID: 35831793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey.
    Lanckohr C; Boeing C; De Waele JJ; de Lange DW; Schouten J; Prins M; Nijsten M; Povoa P; Morris AC; Bracht H
    Ann Intensive Care; 2021 Aug; 11(1):131. PubMed ID: 34436688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.
    Gatti M; Cojutti PG; Bartoletti M; Tonetti T; Bianchini A; Ramirez S; Pizzilli G; Ambretti S; Giannella M; Mancini R; Siniscalchi A; Viale P; Pea F
    Crit Care; 2022 Jun; 26(1):178. PubMed ID: 35701812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and pharmacodynamics of antibiotics in intensive care].
    Sörgel F; Höhl R; Glaser R; Stelzer C; Munz M; Vormittag M; Kinzig M; Bulitta J; Landersdorfer C; Junger A; Christ M; Wilhelm M; Holzgrabe U
    Med Klin Intensivmed Notfmed; 2017 Feb; 112(1):11-23. PubMed ID: 27778050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators in the Clinical Implementation of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: A Critical Review.
    Abdulla A; van den Broek P; Ewoldt TMJ; Muller AE; Endeman H; Koch BCP
    Ther Drug Monit; 2022 Feb; 44(1):112-120. PubMed ID: 34798631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
    Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study.
    Barreto EF; Chitre PN; Pine KH; Shepel KK; Rule AD; Alshaer MH; Abdul Aziz MH; Roberts JA; Scheetz MH; Ausman SE; Moreland-Head LN; Rivera CG; Jannetto PJ; Mara KC; Boehmer KR
    Ther Drug Monit; 2023 Aug; 45(4):508-518. PubMed ID: 37076424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong.
    Chow TCH; Li JYS; Wong JCL; Poon FMH; Lam HS; Lam TT; Lee CP; Ewig CL; Cheung YT
    Front Pediatr; 2020; 8():538298. PubMed ID: 33330263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.